143 results on '"NOBUNAGA, M."'
Search Results
102. [A case of psoriatic arthritis complicated by iridocyclitis, pericarditis and atlanto-axial subluxation (author's transl)].
103. [Clinical picture of so-called milignant rheumatoid arthritis].
104. [Study on circulating immune complexes in collagen diseases by the polyethylene glycol precipitation method and the polyethylene glycol precipitation-complement consumption test (author's transl)].
105. A case of infection of Yersinia pseudotuberculosis associated with complement abnormalities.
106. Suppression of Fc Receptor and C4.C3 receptors of the granulocytes from patients with systemic lupus erythematosus.
107. [Factors in the serum from patients with systemic lupus erythematosus enhancing superoxide generation by neutrophils].
108. Generation of superoxide by immunologically stimulated normal human neutrophils and possible modulation by intracellular and extracellular SOD and rheumatoid factors.
109. Influences of feeding and drinking on circadian rhythms of opioid peptides in plasma, hypothalamus and pituitary gland in rats.
110. [Proposal of revised criteria for malignant rheumatoid arthritis].
111. Unusual serum protein components in rheumatoid arthritis and their relations to systemic vasculitis.
112. [Malignant rheumatoid arthritis 1. Some clinical characteristics of the so-called malignant rheumatoid arthritis].
113. [Clinical significances of circulating immune complexes in hematologic disorders--detection by C1q deviation test and anti-antibody inhibition test].
114. Serum factors from patients with systemic lupus erythematosus enhancing superoxide generation by normal neutrophils.
115. C1q binding to human vascular smooth muscle cells mediates immune complex deposition and superoxide generation.
116. Human vascular smooth muscle cells and endothelial cells lack catalase activity and are susceptible to hydrogen peroxide.
117. [Antibodies to cytoskeletal systems in patients with adult T-cell leukemia and infectious mononucleosis].
118. Detection of low molecular weight IgM by immunoblot analysis in rheumatoid arthritis.
119. Influences of water deprivation and fasting on hypothalamic, pituitary and plasma opioid peptides and prolactin in rats.
120. [Determination of the immune complex level--with special reference to the complement consumption test].
121. Adult T cell leukemia-lymphoma mimicking rheumatic disease.
122. [Evaluation of disease activity by hand X-ray findings in rheumatoid arthritis].
123. Human plasma proopiomelanocortin N-terminal peptide and adrenocorticotropin: circadian rhythm, dexamethasone suppression, and corticotropin-releasing hormone stimulation.
124. [Clinical significance of serum immune complex in collagen diseases. Relation between diseases and analytic methods].
125. [Does the therapy of RA really progress?].
126. Multiple rheumatoid bursal cysts.
127. A case of palindromic rheumatism suggestive of immune complex disease.
128. Human umbilical cord vein smooth muscle cells lack receptors for C3b and the Fc portion of immunoglobulin G.
129. [Treatment of collagen diseases--a questionnaire survey in Japan (author's transl)].
130. Clinical studies of polymyalgia rheumatica. A proposal of diagnostic criteria.
131. [Immunologic defense mechanism in the solubilization of immune complexes by complement].
132. [Studies on malignant rheumatoid arthritis. 2. Clinical characteristics of malignant rheumatoid arthritis. Supplement--epidemiological survey conducted in the Kyushu area].
133. [Rehabilitation of rheumatoid arthritis (author's transl)].
134. Chemotactic activity generated in human serum from the fifth component of complement by hydrogen peroxide.
135. [Activation mechanism and reaction process of the complement system--the classical pathway].
136. [Quantitative measurement of rheumatoid factor (RF) by turbidimetric immunoassay (TIA)--methodological and clinical investigations].
137. [Rheumatism and collagen diseases].
138. [A CASE OF DERMATOMYOSITIS].
139. [Studies on beta-glucuronidase. II. Clinical application of the assay method of beta-glucuronidase activity using p-nitrophenylglucuronide as the substrate. III. The significance of the serum beta-glucuronidase activity in patients with liver diseases, with special references to its relation with the serum transaminase activity, and to its characteristic behavior in cholangiolitic hepatitis].
140. [Glycogen storage disease in adult brothers--with special reference to association of gout].
141. THE EXPERIMENTAL STUDY ON SERUM BETA-GLUCURONIDASE ACTIVITY AND TRANSAMINASE ACTIVITY IN RATS SUBJECTED TO PARTIAL HEPATECTOMY.
142. [A case of G-myeloma].
143. [Clinical significances of RA-test in liver diseases].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.